Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2008 Oct 17;283(42):28513–28517. doi: 10.1074/jbc.M804729200

Small Heat Shock Protein Activity Is Regulated by Variable Oligomeric Substructure*,S⃞

Justin L P Benesch ‡,1, Marina Ayoub §, Carol V Robinson ‡,2, J Andrew Aquilina §,3
PMCID: PMC2661405  PMID: 18713743

Abstract

The α-crystallins are members of the small heat shock protein family of molecular chaperones that have evolved to minimize intracellular protein aggregation; however, they are also implicated in a number of protein deposition diseases. In this study, we employed novel mass spectrometry techniques to investigate the changes in quaternary structure associated with this switch from chaperone to adjuvant of aggregation. We replicated the oligomeric rearrangements observed for post-translationally modified α-crystallins, without altering the protein sequence, by refolding the α-crystallins in vitro. This refolding resulted in a loss of dimeric substructure concomitant with an augmentation of substrate affinity. We show that packaging of small heat shock proteins into dimeric units is used to control the level of chaperone function by regulating the exposure of hydrophobic surfaces. We propose that a bias toward monomeric substructure is responsible for the aberrant chaperone behavior associated with the α-crystallins in protein deposition diseases.


The small heat shock proteins (sHSPs)4 αA- and αB-crystallin are most prevalent in the vertebrate eye lens, where they are found co-assembled and maintain lens transparency by preventing other proteins from forming light-scattering aggregates (1), but are also found in other tissues (2). It is clear that these proteins have the ability to sequester substrates that have become partially unfolded under conditions of stress to preserve them in a state competent for refolding (36). However, molecular mechanisms of their function and regulation remain incompletely understood, particularly regarding aberrant behavior in the transitions that occur to bring about disease states (7).

Structurally, the sHSPs are characterized by their low monomeric molecular mass, their assembly into oligomers, and the presence of a well conserved “α-crystallin” domain (36). Although crystal structures exist for some of the monodisperse members of the family (3), the extreme polydispersity of many of the mammalian sHSPs, including the α-crystallins, has hampered crystallographic analysis (4). Common to the sHSPs for which high resolution structures have been published is the existence of dimers as “building blocks” of the larger oligomer (3, 6). We have reported that recombinant αA and αB form a range of oligomers with a notable preference for an even number of subunits (9, 10). This suggests that dimeric substructure is a key characteristic of the sHSPs, and indeed, dimers have been proposed as the active “chaperoning unit” of the sHSPs (6). In our previous study on αB isolated from the lens under denaturing conditions, we observed a difference in the proportion of oligomers containing an even or odd number of subunits (11). This observation, along with recent work showing structural changes in the α-crystallins upon renaturation from urea (12), suggests that in vitro refolding provides a means of modulating the quaternary structure of these proteins. Here, we exploit this phenomenon to examine the structural and functional properties of α-crystallins with identical sequence yet differing quaternary structure. Using novel mass spectrometry (MS) approaches, we show that not only do these proteins exist as different sized oligomers, but also that these oligomers have variable building blocks. Moreover, we correlate the loss of dimeric substructure with an augmentation of substrate binding and suggest that it is these changes in local oligomeric organization that provide the molecular mechanism for sHSP regulation.

EXPERIMENTAL PROCEDURES

Expression and Purification—The expression vector pET21b(+) containing the genes for either bovine αA-crystallin or human αB-crystallin was introduced into the BL21(DE3) strain of Escherichia coli by standard methods. Protein expression and purification were performed using methods described previously (13).

1-Anilino-8-naphthalenesulfonic Acid (ANS) Binding—αA and αB solutions of 13.5 mg/ml were used. To effect unfolding of the protein, 12 mg of urea was added to 20 μl of each solution, giving a final volume of 30 μl (6.67 m urea), followed by incubation at room temperature for 30 min. The proteins were refolded by dilution to 0.2 mg/ml with 1320 μl of phosphate-buffered saline (PBS; 100 mm sodium chloride and 50 mm phosphate, pH 7.2). Matching controls were prepared by adding the urea after dilution. ANS (5 μl of a 20 mm stock solution in methanol) was added to each sample (resulting in a methanol concentration of 0.37% (v/v) in the samples), and the fluorescence emission was measured between 400 and 600 nm at an excitation wavelength of 370 nm using a Hitachi F4500 fluorometer. The experiment was also performed, as described above, using 200 mm ammonium acetate instead of PBS as diluent.

Kynurenine Binding—60 mg of urea was added to 100 μl of 4 mg/ml αB in PBS and left at room temperature for 30 min. The protein was refolded by dilution to 1 ml with PBS. Matching controls were prepared by adding the urea after dilution. Urea was removed from the diluted solutions by five consecutive concentration and dilution steps using Biomax concentrators (Millipore). 25 μl of kynurenine (5 mg/ml in PBS) and 2 μl of chloroform were added before being sealed and incubated at 37 °C for 14 days. No significant proteolysis was observed to occur by MS analysis.

MS Analysis—Nanoelectrospray MS of the kynureninemodified αB was performed using a Q-ToF Ultima spectrometer (Waters). Samples were desalted and denatured using C18 ZipTips (Millipore) prior to analysis.

Tandem MS (MS/MS) experiments were performed on a modified Q-ToF 2 instrument as described previously (11). Prior to analysis, ∼2 m g of α-crystallin (30 mg/ml in PBS with or without 6.67 m urea) was loaded onto a Superdex 200 gel filtration column (GE Healthcare) and eluted at 0.3 ml/min with 200 mm ammonium acetate. Chromatography resulted in refolding and/or buffer exchange.

Chaperone Assay—Apo-α-lactalbumin (0.5 mg/ml final concentration) was mixed with αB or recombinant αB(αBR; both at 0.24 mg/ml final concentration) in the presence of 20 mm dithiothreitol. The final sample volumes were 100 μl in 200 mm ammonium acetate. The mixtures and a control of apo-α-lactalbumin were transferred to identical cuvettes and placed in a heated (37 °C) multicell block, and the apparent absorption due to light scattering at 360 nm was monitored using a Cary 400 Scan spectrophotometer.

RESULTS

In Vitro Refolding Enhances the Substrate Affinity of αB-crystallin via Increased Surface Exposure—To structurally reorganize recombinant αB, we subjected the protein to in vitro refolding from a high concentration of urea. We have termed this protein αBR. To investigate any surface changes in the oligomers associated with this refolding, we employed two molecular probes: ANS, which fluoresces in a hydrophobic environment, and the reactive small molecule kynurenine, which can covalently bind to exposed His residues in αB (14). Fig. 1A shows the ANS fluorescence for equimolar concentrations of αB and αBR in both PBS and ammonium acetate. In both cases, the fluorescence intensity of the ANS probe was greater for the refolded protein relative to the original, indicating that a small but significant increase in exposed hydrophobic surface area had occurred. This is in agreement with a recent study examining the biophysical properties of α-crystallin (12). Fig. 1B shows the stoichiometries of relative binding of kynurenine to the surface-exposed His residues of αB, with αBR demonstrating ∼70% more total binding. Furthermore, whereas only doubly modified chains were identified in the case of αB, a distinct proportion of αBR was triply modified. These two probing techniques demonstrate that the refolded proteins are sufficiently different in structure such that they are more susceptible to both ANS binding and kynurenine modification.

FIGURE 1.

FIGURE 1.

A, binding of ANS to αB and αBR in both PBS (dark gray bars) and ammonium acetate (light gray bars) revealed that the refolded protein has more exposed hydrophobic surfaces. The fluorescence observed was 343 and 394 fluorescence units in PBS and 1152 and 1310 fluorescence units in ammonium acetate for αB and αBR, respectively. B, similarly, an increase in the amount of kynurenine (Kyn) binding was observed for the refolded protein. C, assaying the chaperone activity of αB toward apo-α-lactalbumin (αLac) revealed that both proteins reduced the rate of aggregation relative to the control (circles). αBR (inverted triangles) reduced aggregation more efficiently than αB(squares), however, reflecting increased substrate affinity or capacity.

To assess the effect of this structural reorganization on sHSP function, αB and αBR were assayed for their ability to prevent precipitation of the aggregation-prone substrate, reduced apo-α-lactalbumin (Fig. 1C). In the absence of chaperone, a rapid increase in apparent absorbance due to light scattering was observed, indicative of the aggregation of apo-α-lactalbumin. When αB was added, the onset of apo-α-lactalbumin aggregation was considerably delayed, demonstrating the protective ability of this protein. αBR was found to further reduce the level of aggregation, suggesting that αBR has a higher substrate affinity than αB. Therefore, taking our chaperone and surface probing experiments together, it appears that in vitro refolding results in an increase in substrate affinity or capacity via the exposure of new surfaces.

MS/MS Characterizes the Polydisperse sHSP Assemblies—Over the last decade, MS analysis of intact protein assemblies has become a valuable addition to the structural biologists' tool kit, allowing the determination of both structural and dynamical parameters (15). To examine the quaternary arrangement of the α-crystallins, we used a MS/MS approach we previously developed whereby the range of oligomers that comprise the polydisperse ensemble may be identified (11). Fig. 2A shows MS/MS spectra of αBR resulting from the selection and activation of ions in the peak at m/z 10,080 (supplemental Fig. S1). This peak corresponds to all oligomers, each carrying twice as many charges as subunits. At an accelerating voltage of 110 V, some undissociated ions remain, but two additional areas of signal are also observed, in the ranges of m/z 12,000–17,000 and 17,000–28,000 (Fig. 2A, lower panel). At 170 V, the same groups of peaks are observed; however, those at higher m/z dominate the spectrum (Fig. 2A, upper panel). These two ranges correspond to singly and doubly stripped oligomers, i.e. parent oligomers having lost one or two monomers, respectively. Monitoring the relative abundance of ions as a function of the accelerating voltage revealed that this dissociation is a sequential process and allowed us to determine the voltages at which the different dissociation steps occur (Fig. 2B).

FIGURE 2.

FIGURE 2.

A, shown are the MS/MS spectra of αBR at accelerating voltages of 110 V (lower panel) and 170 V (upper panel). Dissociation of monomers from the parent oligomers resulted in singly and doubly stripped oligomers, with more of the latter at the higher voltage. B, plotting the relative abundance of the species as a function of acceleration voltage demonstrated the sequential nature of the dissociation. C, an expansion of the area boxed in A shows the very clear separation of peaks achieved. Doubly stripped species of 23–32 subunits are clearly resolved.

Fig. 2C shows an expansion of the area of the spectrum where doubly stripped oligomers carrying two charges less than subunits are found, i.e. [αBR(n-2)][n-4]+, where n is the number of subunits in the original parent oligomers. Doubly stripped species of 23–32 subunits, which correspond to original oligomers with 25–34 subunits, are clearly observed. In this way, not only can the different oligomeric species that comprise the heterogeneous assembly be identified, despite differing by <5% in mass, but also, from their intensities, their relative abundances can be quantified.

In Vitro Refolding of αA and αB Results in the Loss of Dimeric SubstructureFig. 3A shows the oligomeric distribution of αA and αB prior to and after in vitro refolding. These histograms were obtained from MS/MS experiments as described above. Intensities for peaks corresponding to the charge states of the different doubly stripped oligomers were quantified, and from these, the relative abundances of the original oligomers were obtained. αA and αB exhibit a distribution of oligomeric stoichiometries centered on a 26-mer and a 28-mer, respectively. Moreover, both proteins display a marked preference toward assembling into oligomers with an even number of subunits. αAR and αBR are centered on a 24-mer and 28-mer, respectively, and are therefore comparable with their wild-type equivalents in number of subunits. Notably, however, these proteins have lost their preference for forming even-numbered species. Thus, the dimeric substructure of the wild-type proteins, evidenced by an excess of oligomers with an even number of subunits, is lost upon refolding.

FIGURE 3.

FIGURE 3.

A, histograms derived from MS/MS data show the relative abundances of the oligomeric species that comprise αA and αB. The lower and upper panels correspond to the proteins before and after in vitro refolding, respectively. In each case, the tendency to favor even-numbered oligomers that was evident for the native proteins (lower panels) was abolished (upper panels) by the process of in vitro refolding. B, shown is the percentage of doubly stripped oligomers (DSOs; relative to singly stripped) as a function of initial kinetic energies for αA and αB before and after in vitro refolding. •, oligomers containing an even number of subunits; ○, oligomers containing an odd number of subunits. The dissociation profiles show that oligomers of the α-crystallins with an even number of subunits show differential dissociation behavior compared with odd-numbered oligomers and that this difference is lost upon refolding.

Distinct Substructures within Protein Types Are Found by Gas-phase Dissociation—To further investigate the difference between the quaternary organization of these proteins, we employed a recently developed method of probing substructure by MS (16). This approach involves a detailed examination of the dissociation pathway of protein assemblies during MS/MS. Specifically, we examined the ease of the dissociation step in which an additional monomer is removed from the singly stripped oligomers, the rationale being that different local quaternary arrangements might effect differences in dissociation behavior.

The percentage of species that are doubly stripped (relative to singly stripped) for the four different proteins at a range of accelerating voltages, representing the ease of gas-phase removal of the second subunit, is shown in Fig. 3B. Additionally, they have been separated according to whether they contain an even or odd number of subunits. In all cases, the percentage of doubly stripped oligomers follows a sigmoidal profile. From the first derivative, we obtained the turning points shown in supplemental Table S1. For αAR and αBR, we did not observe a significant difference between the dissociation pathway for odd- and even-numbered oligomers, suggesting there is no difference in substructure between them. This agrees with the evidence from the histograms, which suggests that their suboligomeric organization is exclusively monomeric (Fig. 3A). In the case of αA and αB, however, there is a significant difference between the odd- and even-numbered oligomers, viz. the transition from singly to doubly stripped oligomers occurs at higher initial kinetic energies in the case of the even-numbered oligomers. These results suggest that there is a fundamental difference in the substructure of even- and odd-numbered oligomers. Furthermore, the turning points of the curves are similar for the odd-numbered oligomers of both αB and αBR and for αA and αAR, whereas they are significantly different in the case of the even-numbered pairs (supplemental Table S1). This suggests that the substructure of the different oligomers of αBR as well as αB with an odd numbers of subunits is the same, but that a different substructure is present for αB with an even number of subunits. The same properties were observed for αAR and αA. Combining this with the evidence in Fig. 3A, that dimeric substructure is lost upon in vitro refolding, we suggest that wild-type αA and αB exist as a combination of forms, the extremes of which are oligomers with monomeric substructure and even-numbered oligomers with dimeric substructure.

DISCUSSION

Previously, we have shown that the substructure of αA and αB can be altered by post-translational modification; specifically, phosphorylation of αB (9, 17) and truncation of αA (10) cause a decrease and an increase in the amount of dimeric substructure, respectively. Here, we have extended this work to show that the native proteins themselves exist in an apparent equilibrium between different substructural states, viz. with dimeric or monomeric building blocks (Fig. 4A). This is in addition to both these proteins populating a polydisperse ensemble, existing in an adaptable range of oligomeric sizes (4). As such, we propose a new view of these proteins, viz. that they are heterogeneous in terms of both local and global quaternary organization and that it is likely that this heterogeneity is crucial to their function.

FIGURE 4.

FIGURE 4.

A, we propose that the α-crystallins can exist as oligomers with dimeric or monomeric substructure and combinations thereof. The transition from a relatively inactive, low affinity state to an active high affinity state is dictated by the ratio of the types of substructure in the assembly. Dissociation of dimers to monomers leads to the exposure of surfaces in the former contact regions, thereby increasing substrate affinity. B, we propose that, at an ideal ratio of substructures, the net protection conferred by the proteins is maximized. The observation that the α-crystallins are present in a number of age-related protein deposition diseases indicates, however, that they can also be hyperactivated, giving rise to co-precipitation phenomena in vivo. We suggest that sequence changes such as post-translational modifications or mutations disrupt their dimeric substructure sufficiently such that a critical level of substrate affinity is exceeded. At this point, the proteins lose the ability to limit the number of substrates they bind, leading to aberrant chaperone activity and co-precipitation with client proteins.

By causing shifts in this equilibrium without sequence modification, we have observed that disruption of the dimeric sHSP substructure to form oligomers composed of monomeric building blocks results in an augmentation of chaperone activity. Moreover, the chaperone function of these two states is different: the monomeric substructural state has greater exposed hydrophobic surface area and is consequently more active in protecting against protein precipitation. Similarly, small changes in hydrophobicity causing considerable differences in chaperone activity have been observed upon deamidation of the α-crystallins (18, 19). Here, we have shown that it is not the changes in primary structure caused by post-translational modification but rather the alterations in substructure that they engender that determine chaperone activity.

A recent model of sHSP chaperone function suggests that sHSP oligomers exist in two forms with differential activity: a low affinity state and a high affinity state (3, 20). We propose here that, in the case of the α-crystallins, these two forms correspond to oligomers with dimeric and monomeric substructure, respectively (Fig. 4A). We suggest that it is the ratio of these two forms that determines the overall efficacy of the chaperone ensemble. Stressors, or irreversible protein modification, affect this ratio by causing sufficient destabilization such that dimeric substructure is perturbed. This leads to an increase in substrate affinity by exposing the former interfacial regions to unfolded substrate proteins. This ability to package subunits into dimers for subsequent activation represents an elegant mechanism of regulating the chaperone activity of these sHSPs.

There is a growing body of literature in which αB has been reported to be involved in protein deposition diseases (7), potentially due to co-precipitation of the chaperone with substrate proteins in vivo (21). An explanation for this that arises from the work presented here is that mutation, post-translational modification, or some other type of alteration may disrupt the dimeric substructure of αB such that a critical amount of binding surfaces is exceeded. Indeed, we have shown previously that phosphorylation of αB can result in a loss of dimeric preference and consequent uncontrolled co-aggregation behavior (9). Similarly, an inheritable R120G mutation in αB has been shown to result in protein deposition disorders, including cataracts and cardiomyopathy (8, 22). In vitro measurements of R120G versus wild-type αB indicated that a dramatic increase in substrate affinity is responsible for R120G forming insoluble co-aggregates with the client proteins (21).

We hypothesize that this chaperone hyperactivity associated with some mutations and post-translational modifications is the result of a shift in the ratio of dimeric to monomeric substructure of αB. If we consider the level of αB function to be determined by position on a continuum of this ratio, then aberrant chaperone behavior occurs when the ideal substructural balance is exceeded (Fig. 4B). Thus, the chaperone function of sHSPs might be viewed as an exquisite balancing act that is, in the case of some protein-misfolding disorders, tipped such that the chaperone itself contributes to the disease.

Supplementary Material

[Supplemental Data]
M804729200_index.html (1.1KB, html)

Acknowledgments

We thank Joe Horwitz and Lin Lin Ding (Jules Stein Institute, UCLA) for providing the recombinant protein and Heath Ecroyd (University of Adelaide) for critical reading of the manuscript.

*

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

S⃞

The on-line version of this article (available at http://www.jbc.org) contains supplemental Fig. S1 and Table S1.

Footnotes

4

The abbreviations used are: sHSP, small heat shock protein; MS, mass spectrometry; ANS, 1-anilino-8-naphthalenesulfonic acid; PBS, phosphate-buffered saline; MS/MS, tandem MS; αBR, recombinant αB.

References

  • 1.Brady, J. P., Garland, D., Duglas-Tabor, Y., Robison, W. G., Jr., Groome, A., and Wawrousek, E. F. (1997) Proc. Natl. Acad. Sci. U. S. A. 94 884-889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kappe, G., Franck, E., Verschuure, P., Boelens, W. C., Leunissen, J. A., and de Jong, W. W. (2003) Cell Stress Chaperones 8 53-61 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Haslbeck, M., Franzmann, T., Weinfurtner, D., and Buchner, J. (2005) Nat. Struct. Mol. Biol. 12 842-846 [DOI] [PubMed] [Google Scholar]
  • 4.Horwitz, J. (2003) Exp. Eye Res. 76 145-153 [DOI] [PubMed] [Google Scholar]
  • 5.Narberhaus, F. (2002) Microbiol. Mol. Biol. Rev. 66 64-93 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.van Montfort, R., Slingsby, C., and Vierling, E. (2002) Adv. Protein Chem. 59 105-156 [DOI] [PubMed] [Google Scholar]
  • 7.Sun, Y., and MacRae, T. H. (2005) FEBS J. 272 2613-2627 [DOI] [PubMed] [Google Scholar]
  • 8.Rajasekaran, N. S., Connell, P., Christians, E. S., Yan, L. J., Taylor, R. P., Orosz, A., Zhang, X. Q., Stevenson, T. J., Peshock, R. M., Leopold, J. A., Barry, W. H., Loscalzo, J., Odelberg, S. J., and Benjamin, I. J. (2007) Cell 130 427-439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Aquilina, J. A., Benesch, J. L. P., Ding, L. L., Yaron, O., Horwitz, J., and Robinson, C. V. (2004) J. Biol. Chem. 279 28675-28680 [DOI] [PubMed] [Google Scholar]
  • 10.Aquilina, J. A., Benesch, J. L. P., Ding, L. L., Yaron, O., Horwitz, J., and Robinson, C. V. (2005) J. Biol. Chem. 280 14485-14491 [DOI] [PubMed] [Google Scholar]
  • 11.Aquilina, J. A., Benesch, J. L. P., Bateman, O. A., Slingsby, C., and Robinson, C. V. (2003) Proc. Natl. Acad. Sci. U. S. A. 100 10611-10616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Saha, S., and Das, K. P. (2007) Protein J. 26 315-326 [DOI] [PubMed] [Google Scholar]
  • 13.Horwitz, J., Huang, Q. L., Ding, L., and Bova, M. P. (1998) Methods Enzymol. 290 365-383 [DOI] [PubMed] [Google Scholar]
  • 14.Aquilina, J. A., and Truscott, R. J. (2001) Biochem. Biophys. Res. Commun. 285 1107-1113 [DOI] [PubMed] [Google Scholar]
  • 15.Robinson, C. V., Sali, A., and Baumeister, W. (2007) Nature 450 973-982 [DOI] [PubMed] [Google Scholar]
  • 16.Benesch, J. L. P., Aquilina, J. A., Ruotolo, B. T., Sobott, F., and Robinson, C. V. (2006) Chem. Biol. 13 597-605 [DOI] [PubMed] [Google Scholar]
  • 17.Ecroyd, H., Meehan, S., Horwitz, J., Aquilina, J. A., Benesch, J. L. P., Robinson, C. V., Macphee, C. E., and Carver, J. A. (2007) Biochem. J. 401 129-141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gupta, R., and Srivastava, O. P. (2004) J. Biol. Chem. 279 44258-44269 [DOI] [PubMed] [Google Scholar]
  • 19.Gupta, R., and Srivastava, O. P. (2004) Investig. Ophthalmol. Vis. Sci. 45 206-214 [DOI] [PubMed] [Google Scholar]
  • 20.Claxton, D. P., Zou, P., and McHaourab, H. S. (2008) J. Mol. Biol. 375 1026-1039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bova, M. P., Yaron, O., Huang, Q., Ding, L., Haley, D. A., Stewart, P. L., and Horwitz, J. (1999) Proc. Natl. Acad. Sci. U. S. A. 96 6137-6142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vicart, P., Caron, A., Guicheney, P., Li, Z., Prevost, M. C., Faure, A., Chateau, D., Chapon, F., Tome, F., Dupret, J. M., Paulin, D., and Fardeau, M. (1998) Nat. Genet. 20 92-95 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Supplemental Data]
M804729200_index.html (1.1KB, html)
M804729200_1.pdf (59.6KB, pdf)

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES